CD34 and myelofibrosis: In pathological situations, the number of CD34+ and of HSPCs can be either lower, as in Fanconi anemia [44], unchanged, as in low risk BM failure MDS, or increased, as in high risk MDS and in myelofibrosis [29,45,46].